Cargando…

Upregulated Heat Shock Proteins After Hyperthermic Chemotherapy Point to Induced Cell Survival Mechanisms in Affected Tumor Cells From Peritoneal Carcinomatosis

In patients with peritoneal carcinomatosis cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) represents a promising treatment strategy. Here, we studied the role of hyperthermic chemotherapy on heat shock protein (HSP) expression and induction of tumor cell death...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grimmig, Tanja, Moll, Eva-Maria, Kloos, Kerstin, Thumm, Rebecca, Moench, Romana, Callies, Simone, Kreckel, Jennifer, Vetterlein, Malte, Pelz, Joerg, Polat, Buelent, Tripathi, Sudipta, Rehder, Roberta, Ribas, Carmen M, Chandraker, Anil, Germer, Christoph-T, Waaga-Gasser, Ana Maria, Gasser, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791678/ https://www.ncbi.nlm.nih.gov/pubmed/29403306 http://dx.doi.org/10.1177/1179064417730559

Ejemplares similares

Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer
por: Grimmig, Tanja, et al.
Publicado: (2016)

Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer
por: Moench, Romana, et al.
Publicado: (2016)

Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects
por: Grimmig, Tanja, et al.
Publicado: (2019)

TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer
por: GRIMMIG, TANJA, et al.
Publicado: (2015)

Clinical Significance of Disseminated Pluripotent Tumor Cell Signature Expression in the Bone Marrow from Patients with Colorectal Cancer
por: Gasser, Martin, et al.
Publicado: (2017)

The role of FOXP3 in disease progression in colorectal cancer patients
por: Grimmig, Tanja, et al.
Publicado: (2013)

Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations
por: Pelz, Joerg OW, et al.
Publicado: (2006)

A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis
por: Pelz, Joerg OW, et al.
Publicado: (2005)

Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer
por: Moench, Romana, et al.
Publicado: (2022)

Adenosinergic Pathway and Linked Suppression: Two Critical Suppressive Mechanisms of Human Donor Antigen Specific Regulatory T Cell Lines Expanded Post Transplant
por: Tripathi, Sudipta, et al.
Publicado: (2022)

Expression of Foxp3 in Colorectal Cancer but Not in Treg Cells Correlates with Disease Progression in Patients with Colorectal Cancer
por: Kim, Mia, et al.
Publicado: (2013)

Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades
por: Kerscher, A G, et al.
Publicado: (2013)

Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis
por: Duhr, Carolin D, et al.
Publicado: (2011)

Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin – a longitudinal experience from a prospectively collected database of 1108 patients
por: Seyfried, Florian, et al.
Publicado: (2015)

PDE4D targeting enhances anti-tumor effects of sorafenib in clear cell renal cell carcinoma and attenuates MAPK/ERK signaling in a CRAF-dependent manner
por: Cao, Minghua, et al.
Publicado: (2022)

Tumor Necrosis Factor-α is Associated with Positive Lymph Node Status in Patients with Recurrence of Colorectal Cancer – Indications for Anti-TNF-α Agents in Cancer Treatment
por: Grimm, M., et al.
Publicado: (2010)

CIP2A Influences Survival in Colon Cancer and Is Critical for Maintaining Myc Expression
por: Wiegering, Armin, et al.
Publicado: (2013)

A prospective study on histone γ-H2AX and 53BP1 foci expression in rectal carcinoma patients: correlation with radiation therapy-induced outcome
por: Djuzenova, Cholpon S., et al.
Publicado: (2015)

Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases
por: Grimm, Martin, et al.
Publicado: (2010)

The intraportal injection model: A practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer
por: Thalheimer, Andreas, et al.
Publicado: (2009)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis
por: Ellison, Lynne M., et al.
Publicado: (2017)

KMP01D Demonstrates Beneficial Anti-inflammatory Effects on Immune Cells: An ex vivo Preclinical Study of Patients With Colorectal Cancer
por: Gasser, Martin, et al.
Publicado: (2020)

Evaluation of Best Supportive Care and Systemic Chemotherapy as Treatment Stratified according to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for Peritoneal Carcinomatosis of Colorectal Origin
por: Pelz, Joerg OW, et al.
Publicado: (2010)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
por: Roh, Seung Jae, et al.
Publicado: (2020)

The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Clinical course for patients with peritoneal carcinomatosis excluded from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Rodt, Anne Peen, et al.
Publicado: (2013)

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
por: Vassos, Nikolaos, et al.
Publicado: (2016)

Is There a Role for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis Due to Uterine Cancer?
por: Düzgün, Özgül, et al.
Publicado: (2022)

Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery for Colorectal Peritoneal Carcinomatosis Patients: A Review
por: Alhumaidan, Sarah S, et al.
Publicado: (2022)

Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy
por: Song, Young, et al.
Publicado: (2023)

A Comparison Between Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis of Colonic Origin in Rats
por: Aarts, F., et al.
Publicado: (2007)

Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis
por: Nowacki, Maciej, et al.
Publicado: (2015)

Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index
por: Trilling, Bertrand, et al.
Publicado: (2021)

Repeated cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study
por: Paasch, C., et al.
Publicado: (2021)

Outcomes of Cytoreduction and Oxaliplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis From Colorectal Cancer
por: Alhumaid, Moayad, et al.
Publicado: (2021)

The impact of hyperthermic intraperitoneal chemotherapy and cytoreductive surgery on clinical outcomes and quality of life of patients with peritoneal carcinomatosis
por: Bondar, Oleksandr Vadymovych, et al.
Publicado: (2021)

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: VALLEJO, JAIRO SEBASTIÁN ASTUDILLO, et al.
Publicado: (2023)

Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Glockzin, Gabriel, et al.
Publicado: (2009)

Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis
por: Nowacki, Maciej, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3nd2agnn6bjojn8ua4h2bdbutd